The Bw4/Bw6 difference between HLA-B*0802 and HLA-B*0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells

被引:17
作者
Arnett, KL
Huang, W
Valiante, NM
Barber, LD
Parham, P [1 ]
机构
[1] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA
关键词
HLA-B8; subtypes; peptide-binding specificity; endogenous peptide; alloreactivity;
D O I
10.1007/s002510050400
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
HLA-B*0801 is unique among HLA-B allotypes in having dominant amino acid anchors at positions 3 and 5 of the peptide-binding motif. HLA-B*-0802 is a variant of HLA-B*0801 in which the Bw6 sequence motif is replaced by a Bw4 sequence motif. This change, involving substitutions at positions 77. 80, 81, 82, and 83 of the B*08 heavy chain, is probably the result of a single evolutionary event of interallelic conversion. Moreover, the difference between B*0802 and B*0801 is sufficient to stimulate a cytotoxic T-cell response. To assess further the functional Impact of the Bw4 motif on a B8 background, we compared the peptide-binding specificity of the B*0801 and B*0802 allotypes by sequencing the mixture of peptides endogenously bound to B*0802 and 12 individual peptides purified from that mixture. The HLA-B*0802 allotype, while able to bind some peptides bound by B*0801: has a broader repertoire of endogenously bound peptides than B*0801: the peptides bound by B*0802 are more variable In length and exhibit greater diversity in the carboxyl-terminal amino acid which interacts with the F pocket.
引用
收藏
页码:56 / 61
页数:6
相关论文
共 19 条
  • [1] EXPRESSION OF AN UNUSUAL BW4 EPITOPE BY A SUBTYPE OF HLA-B8 [B-ASTERISK-0802]
    ARNETT, KL
    ADAMS, EJ
    GUMPERZ, JE
    DARKE, C
    MARSH, SGE
    GELSTHORPE, K
    PARHAM, P
    [J]. TISSUE ANTIGENS, 1995, 46 (04): : 316 - 321
  • [2] OVERLAP IN THE REPERTOIRES OF PEPTIDES BOUND IN-VIVO BY A GROUP OF RELATED CLASS-I HLA-B ALLOTYPES
    BARBER, LD
    GILLECECASTRO, B
    PERCIVAL, L
    LI, XB
    CLAYBERGER, C
    PARHAM, P
    [J]. CURRENT BIOLOGY, 1995, 5 (02) : 179 - 190
  • [3] Nomenclature for factors of the HLA system, 1996
    Bodmer, JG
    Marsh, SGE
    Albert, ED
    Bodmer, WF
    Bontrop, RE
    Charron, D
    Dupont, B
    Erlich, HA
    Fauchet, R
    Mach, B
    Mayr, WR
    Parham, P
    Sasazuki, T
    Schreuder, GMT
    Strominger, JL
    Svejgaard, A
    Terasaki, PI
    [J]. HUMAN IMMUNOLOGY, 1997, 53 (01) : 98 - 128
  • [4] BRODSKY FM, 1982, J IMMUNOL, V128, P129
  • [5] NK3-SPECIFIC NATURAL-KILLER-CELLS ARE SELECTIVELY INHIBITED BY BW4-POSITIVE HLA ALLELES WITH ISOLEUCINE-80
    CELLA, M
    LONGO, A
    FERRARA, GB
    STROMINGER, JL
    COLONNA, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1235 - 1242
  • [6] DIBRINO M, 1994, J IMMUNOL, V152, P620
  • [7] THE BW4 PUBLIC EPITOPE OF HLA-B MOLECULES CONFERS REACTIVITY WITH NATURAL-KILLER-CELL CLONES THAT EXPRESS NKB1, A PUTATIVE HLA RECEPTOR
    GUMPERZ, JE
    LITWIN, V
    PHILLIPS, JH
    LANIER, LL
    PARHAM, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) : 1133 - 1144
  • [8] Gumperz JE, 1997, J IMMUNOL, V158, P5237
  • [9] MOLECULAR ANALYSIS OF THE ASSOCIATION OF HLA-B53 AND RESISTANCE TO SEVERE MALARIA
    HILL, AVS
    ELVIN, J
    WILLIS, AC
    AIDOO, M
    ALLSOPP, CEM
    GOTCH, FM
    GAO, XM
    TAKIGUCHI, M
    GREENWOOD, BM
    TOWNSEND, ARM
    MCMICHAEL, AJ
    WHITTLE, HC
    [J]. NATURE, 1992, 360 (6403) : 434 - 439
  • [10] Imanishi T., 1992, HLA 1991, P1065